menu search

Tg therapeutics: a buy for its monster multiple sclerosis agent

New earning asset BRIUMVI launched in February and got approved in Europe. BRIUMVI is better than the standard, which already achieved ...

June 15, 2023, 3:33 am

Disney sets date for new 'star wars' film, delays 'avatar' sequels

Walt Disney Co on Tuesday announced that a new "Star Wars" film will reach theaters in 2026 but said it would postpone the release of the next three i...

June 13, 2023, 1:44 pm

Intel could be investor in chip designer arm's blockbuster ipo

SoftBank-backed Arm is in talks with Intel as a potential strategic investor to anchor one of the year's biggest initial public offerings, reports say...

June 13, 2023, 6:53 am

Disney's pixar seeks return of box office magic with 'elemental'

When Pixar Animation Studios releases its 27th feature film in theaters on Friday, the pioneering studio behind ...

June 13, 2023, 6:04 am

F.t.c. said to plan to sue to stop microsoft's activision deal from closing

The agency had sued to block the blockbuster deal last year. Its latest move in federal court would pre...

June 12, 2023, 1:43 pm

Usd/cad takes a look below key trendline support to start the week

The pair has heavily respected the key trendline support (white line) from the November and early February lows over the past few months. But sellers ...

June 12, 2023, 10:49 am

Gold weekly forecast: gold (xau/usd0 prices delicately poised heading into blockbuster week

A pivotal week ahead not just for gold prices but markets as a whole. Will the FOMC meeting see gold return to the $2000 handle or will the long-await...

June 10, 2023, 4:00 pm

2 top biotech stocks to buy in june

The biotech sector remains a fertile place of innovation that can enrich an investor. Gilead has a potential oncology blockbuster, and the stock offer...

June 9, 2023, 10:15 am

Wall street loves these 3 growth stocks -- should you?

Brookfield Renewable has tremendous opportunities, thanks to carbon emission reduction efforts. CRISPR Therapeutics could soon have a ...

June 9, 2023, 5:50 am

This red-hot growth stock has soared 885% in just 12 months

Viking Therapeutics is a biotech with multiple potential blockbuster drugs in its portfolio. Encouragin...

June 8, 2023, 10:07 am

Gamestop earnings are today. the stock is gaining into the report.

The retailer is expected to benefit from a wave of major blockbuster videogame releases, which started ...

June 7, 2023, 11:05 am

Analysis: stelara patent deal puts j&j back on path to $57 bln 2025 revenue forecast

Johnson & Johnson's legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster ps...

June 5, 2023, 6:15 am

Investors are underestimating the impact of nintendo's latest blockbuster game

Zelda: Tears of the Kingdom could be the highest-grossing game of 2023. The title could clear $1 billion in profits for Nintendo....

June 3, 2023, 9:15 am

Coherus biosciences to launch humira biosimilar at $995 per carton

Coherus BioSciences Inc said on Thursday it plans to launch a biosimilar of AbbVie Inc's blockbuster ar...

June 1, 2023, 9:24 am

Nvidia's blockbuster quarter

And we've got an interview with Yancey Spruill, CEO of cloud service provider DigitalOcean....

June 1, 2023, 7:53 am

Salesforce earnings are coming. what to expect.

Software giant Salesforce had a blockbuster January quarter. It reports earnings for the April quarter ...

May 31, 2023, 11:20 am

Nvidia entices chipmakers higher as it joins the $1t club

NVIDIA Corporation (NASDAQ:NVDA) became the latest tech company to join the $1 trillion club Tuesday as a slate of positive recent news - including ...

May 30, 2023, 11:54 am

Why nvidia, c3.ai, and qualcomm stocks keep going up

Nvidia's blockbuster earnings last week gave momentum to AI stocks. A flurry of press releases over the...

May 30, 2023, 11:53 am

Nasdaq etfs won in may: further rally expected ahead

The Nasdaq has reported a blockbuster performance in May, helped by the AI frenzy, cheaper valuation, c...

May 30, 2023, 9:40 am

Pfizer's heading for a patent cliff. is the stock still a buy?

Pfizer's older blockbusters are set to lose exclusivity soon, meaning billions of dollars in lost revenue. But the company's near-to-market candidates...

May 30, 2023, 5:30 am


Search within

Pages Search Results: